Silverwood Partners
  • About Us
    • Overview
    • Why Silverwood?
    • Careers
    • Our Location
    • Connect With Us
  • Insights & Analysis
    • Newsletters
    • Intelligence Briefs
    • Events
    • Connect With Us
  • Team
    • All Team
    • Technology
    • Consumer
    • Healthcare
  • Industry Experience
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
  • Services
    • Mergers & Acquisitions
    • Private Placements
    • Connect With Us
  • Transactions
    • All Transactions
    • Technology
    • Consumer
    • Healthcare
    • Connect With Us
Select Page
Healthcare Private Placement and M&A Transactions Review Week Ending May 21, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending May 21, 2023

by Jonathan Hodson-Walker | May 25, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Ensoma: The company raised $135 million of Series B venture funding in a deal led by 5AM Ventures and Arix Bioscience on May 16, 2023, putting the company’s pre-money valuation at $130...
Healthcare Private Placement and M&A Transactions Review Week Ending May 14, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending May 14, 2023

by Jonathan Hodson-Walker | May 18, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Cullgen: The company raised $40 million through a combination of debt and Series C venture funding in a deal led by Wuxi AstraZeneca CICC Venture Capital Partnership on May 8, 2023, putting the...
Healthcare Private Placement and M&A Transactions Review Week Ending May 7, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending May 7, 2023

by Jonathan Hodson-Walker | May 11, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Convergent Therapeutics: The company raised $90 million of Series A1 venture funding in a deal led by OrbiMed and RA Capital Management on May 3, 2023, putting the company’s pre-money...
Healthcare Private Placement and M&A Transactions Review Week Ending April 30, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 30, 2023

by Jonathan Hodson-Walker | May 4, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Orbital Therapeutics: The company raised $270 million of Series A venture funding in a deal led by ARCH Venture Partners on April 26, 2023. Alexandria Venture Investments, Heritage Medical...
Healthcare Private Placement and M&A Transactions Review Week Ending April 23, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 23, 2023

by Jonathan Hodson-Walker | Apr 26, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions Distalmotion: The company raised $150 million of venture funding in a deal led by Revival Healthcare Capital on April 19, 2023. Other undisclosed investors also participated in the round. The...
Healthcare Private Placement and M&A Transactions Review Week Ending April 16, 2023

Healthcare Private Placement and M&A Transactions Review Week Ending April 16, 2023

by Jonathan Hodson-Walker | Apr 20, 2023 | Healthcare

Strategy | Financing Highlight  Private Placement / Financing Transactions TORL BioTherapeutics: The company raised $158 million of Series B venture funding in a deal led by Goldman Sachs Asset Management April 13, 2023. Moore Strategic Ventures and 7 other investors...
« Older Entries
Next Entries »

Search

Recent Posts

  • Technology Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Healthcare Private Placement and M&A Transactions Review Week Ending September 7, 2025
  • Technology Private Placement and M&A Transactions Review Week Ending August 31, 2025
  • Consumer Private Placement and M&A Transactions Review Week Ending August 31, 2025

Categories

Archives